{"entity":{"type":"insider","cik":"0001977231","url":"/insider/0001977231","json_url":"/insider/0001977231.json","name":"DOW GEOFFREY S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":6,"first":"2024-02-02","last":"2026-06-15","span_basis":"filed_date"},"name_variants":[{"name":"DOW GEOFFREY S","source":"filing","n_filings":6,"first_seen":"2024-02-02","last_seen":"2026-06-15"}],"transactions":[{"id":6236475,"accession":"0001213900-26-068853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-068853","line_url":"/filing/0001213900-26-068853#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7350.0,"shares_display":"7,350","price_per_share":1.3784,"price_display":"1.38","price_state":"stated","total_value":10131.24,"total_display":"10,131.24","total_whole":"10,131","shares_owned_after":24131.0,"shares_owned_after_display":"24,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-15","scope":"insider"},{"id":5184513,"accession":"0001213900-25-122379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-122379","line_url":"/filing/0001213900-25-122379#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9670.0,"shares_display":"9,670","price_per_share":0.8024,"price_display":"0.80","price_state":"stated","total_value":7759.208,"total_display":"7,759.21","total_whole":"7,759","shares_owned_after":59618.0,"shares_owned_after_display":"59,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider"},{"id":4756757,"accession":"0001213900-25-120948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-120948","line_url":"/filing/0001213900-25-120948#line-2","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3613.0,"shares_display":"3,613","price_per_share":0.9184,"price_display":"0.92","price_state":"stated","total_value":3318.1792,"total_display":"3,318.18","total_whole":"3,318","shares_owned_after":49948.0,"shares_owned_after_display":"49,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-12","scope":"insider"},{"id":4756753,"accession":"0001213900-25-120948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-120948","line_url":"/filing/0001213900-25-120948#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9350.0,"shares_display":"9,350","price_per_share":0.9504,"price_display":"0.95","price_state":"stated","total_value":8886.24,"total_display":"8,886.24","total_whole":"8,886","shares_owned_after":46335.0,"shares_owned_after_display":"46,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-12","scope":"insider"},{"id":2548326,"accession":"0001213900-24-107011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-107011","line_url":"/filing/0001213900-24-107011#line-3","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35823.0,"shares_display":"35,823","price_per_share":1.2719,"price_display":"1.27","price_state":"stated","total_value":45563.2737,"total_display":"45,563.27","total_whole":"45,563","shares_owned_after":94580.0,"shares_owned_after_display":"94,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-09","scope":"insider"},{"id":2548322,"accession":"0001213900-24-107011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-107011","line_url":"/filing/0001213900-24-107011#line-2","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20579.0,"shares_display":"20,579","price_per_share":1.1989,"price_display":"1.20","price_state":"stated","total_value":24672.1631,"total_display":"24,672.16","total_whole":"24,672","shares_owned_after":58757.0,"shares_owned_after_display":"58,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-09","scope":"insider"},{"id":2548317,"accession":"0001213900-24-107011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-107011","line_url":"/filing/0001213900-24-107011#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17549.0,"shares_display":"17,549","price_per_share":1.1123,"price_display":"1.11","price_state":"stated","total_value":19519.7527,"total_display":"19,519.75","total_whole":"19,520","shares_owned_after":38178.0,"shares_owned_after_display":"38,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider"},{"id":3248170,"accession":"0001213900-24-101110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-101110","line_url":"/filing/0001213900-24-101110#line-3","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.9129,"price_display":"0.91","price_state":"stated","total_value":3195.15,"total_display":"3,195.15","total_whole":"3,195","shares_owned_after":20629.0,"shares_owned_after_display":"20,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-21","scope":"insider"},{"id":3248162,"accession":"0001213900-24-101110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-101110","line_url":"/filing/0001213900-24-101110#line-2","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.9243,"price_display":"0.92","price_state":"stated","total_value":924.3,"total_display":"924.30","total_whole":"924","shares_owned_after":17129.0,"shares_owned_after_display":"17,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-21","scope":"insider"},{"id":3248156,"accession":"0001213900-24-101110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-101110","line_url":"/filing/0001213900-24-101110#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.8992,"price_display":"0.90","price_state":"stated","total_value":2248.0,"total_display":"2,248.00","total_whole":"2,248","shares_owned_after":16129.0,"shares_owned_after_display":"16,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-21","scope":"insider"},{"id":2698596,"accession":"0001213900-24-009603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-009603","line_url":"/filing/0001213900-24-009603#line-1","is_derivative":false,"issuer_cik":"0001946563","issuer_name":"60 DEGREES PHARMACEUTICALS, INC.","issuer_ticker":"SXTP","issuer_name_source":null,"issuer_url":"/issuer/0001946563","owner_cik":"0001977231","owner_name":"DOW GEOFFREY S","owner_display_name":"DOW GEOFFREY S","owner_url":"/insider/0001977231","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25974.0,"shares_display":"25,974","price_per_share":0.375,"price_display":"0.38","price_state":"stated","total_value":9740.25,"total_display":"9,740.25","total_whole":"9,740","shares_owned_after":703599.0,"shares_owned_after_display":"703,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001946563","name":"60 DEGREES PHARMACEUTICALS, INC.","url":"/issuer/0001946563","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2024-02-02","last_seen":"2026-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001977231","retrieved_at":"2026-08-26T11:51:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}